薬物依存症（Drug Addiction）：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Drug Addiction 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Drug Addiction to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Drug Addiction to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Drug Addiction 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Drug Addiction Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Drug Addiction 33
May 27, 2014: Biotie: nepicastat study in cocaine dependence completes enrollment ahead of schedule – top-line data expected around end 2014 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
RTI International 34
Clinical Trial Overview of RTI International 34
Johnson & Johnson 35
Clinical Trial Overview of Johnson & Johnson 35
Alkermes Inc. (Inactive) 36
Clinical Trial Overview of Alkermes Inc. (Inactive) 36
SK Holdings Co., Ltd. 37
Clinical Trial Overview of SK Holdings Co., Ltd. 37
Reckitt Benckiser Group Plc 38
Clinical Trial Overview of Reckitt Benckiser Group Plc 38
GlaxoSmithKline plc 39
Clinical Trial Overview of GlaxoSmithKline plc 39
Embera NeuroTherapeutics, Inc. 40
Clinical Trial Overview of Embera NeuroTherapeutics, Inc. 40
Catalyst Pharmaceutical Partners, Inc. 41
Clinical Trial Overview of Catalyst Pharmaceutical Partners, Inc. 41
Gilead Sciences, Inc. 42
Clinical Trial Overview of Gilead Sciences, Inc. 42
D&A Pharma SAS 43
Clinical Trial Overview of D&A Pharma SAS 43
Clinical Trial Overview of Top Institutes / Government 44
National Institute on Drug Abuse 44
Clinical Trial Overview of National Institute on Drug Abuse 44
Yale University 46
Clinical Trial Overview of Yale University 46
University of Pennsylvania 47
Clinical Trial Overview of University of Pennsylvania 47
New York State Psychiatric Institute 48
Clinical Trial Overview of New York State Psychiatric Institute 48
University of California, Los Angeles 49
Clinical Trial Overview of University of California, Los Angeles 49
Johns Hopkins University 50
Clinical Trial Overview of Johns Hopkins University 50
Medical University of South Carolina 51
Clinical Trial Overview of Medical University of South Carolina 51
Baylor College of Medicine 52
Clinical Trial Overview of Baylor College of Medicine 52
University of Arkansas 53
Clinical Trial Overview of University of Arkansas 53
University of Kentucky 54
Clinical Trial Overview of University of Kentucky 54
Five Key Clinical Profiles 55
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76